Laboratory Reference Grade CompoundsInsulation Foam Protected • Dispatched Nationwide
Dispatched from Metro Manila · J&T Express•Instant GCash, Maya & Bank QR
Orforglipron (12mg Research Vial)
RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓₱3,600.00
Out of stock
Net Content12MG
InclusionVial + BAC Water
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (12MG)
Diluent:mL
Concentration12.00 mg/mLin 1.0mL BAC
Standard Dose3.0 mg – 12.0 mg Daily Analytical WindowSyringe: 50.0 units (0.50 mL)
Scale (1 Unit)120 mcgper 0.01 mL (U-100)
✓ Includes 10mL Bacteriostatic Water USPMonograph SOP →
Orforglipron (12mg Research Vial)12MG · Vial + BAC Water
₱3,600.00
1
Technical Specification & Protocol Dossier
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
P
Research MonographPharmacological Profile & Mechanism of Action
What it is: Orforglipron (LY3502970) is a pioneering non-peptide small-molecule agonist of the GLP-1 receptor, engineered to achieve high oral bioavailability without requiring absorption enhancers.
How it works: Orforglipron binds to the transmembrane domain of the GLP-1 receptor, allosterically inducing downstream cAMP accumulation and glucose-dependent insulin secretion while profoundly suppressing appetite.
Why researchers study it: Researched in Phase 3 clinical trials (ACHIEVE program) for oral efficacy rivaling injectable peptide incretins, achieving significant reductions in HbA1c and body weight.
Compound & Molecular Specifications
Certificate of Analysis StandardsTarget CategoryMetabolic Signaling & Incretins
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number2212020-52-3
PubChem CID155196440↗
Molecular Weight766.8 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options12MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaC42H44F2N6O6
